Use of anti-D in immune thrombocytopenic purpura as a means to prevent splenectomy: Case reports from two university hospital medical centers

Seminars in Hematology

Volumn 37, Issue 1 SUPPL. 1, 2000, Pages 45-49

  Waintraub, Stanley E ^a,c   Brody, Jerome I ^a,b  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b ALLEGHENY UNIVERSITY HOSPITALS   (United States)

^c Northern New Jersey Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RHESUS D ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; PRIORITY JOURNAL; SPLENECTOMY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 0033980676     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90119-7     Document Type: Article

References (13)

1. JB Bussel I Schulman MW Hilgartner Intravenous use of gammaglobulin in the treatment of chronic immune thrombocytopenic purpura as a means to defer splenectomy J Pediatr 103 1983 651 654
2. JP Hollenberg LL Subak JJ Ferry Cost-effectiveness of splenectomy versus intravenous gammaglobulin in treatment of chronic immune thrombocytopenic purpura in childhood J Pediatr 112 1988 530 534
3. A Scaradavou B Woo BMR Woloski Intravenous anti-D treatment in immune thrombocytopenic purpura: Experience in 272 patients Blood 89 1997 2689 2700
4. o(D)) in autoimmune thrombocytopenia: Correlation with response to high dose IgG and the degree of haemolysis Blut 52 1986 117 121
5. RE Ware SA Zimmerman Anti-D: Mechanisms of action Semin Hematol 35 1998 14 22 (suppl 1)
6. SA Zimmerman FJ Malinoski RE Ware Immunologic effects of anti-D (WinRho-SD) in children with immune thrombocytopenic purpura Am J Hematol 57 1998 131 138
7. JB Bussel JN Graziano RP Kimberly Intravenous anti-D treatment of immune thrombocytopenic purpura: Analysis of efficacy, toxicity, and mechanism of effect Blood 77 1991 1884 1893
8. NA Smith RK Chakraverty D Obeid Long-term response in a patient with ITP following low-dose anti-D immunoglobulin therapy Autoimmunity 4 1989 115 117
9. PA Ballem GM Segal JR Stratton Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: Evidence for both impaired platelet production and increased platelet clearance J Clin Invest 80 1987 33 40
10. P Imbach JP Wagner W Berchtold Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood Lancet 2 1985 464 468
11. VS Blanchette B Luke M Andrew A prospective, randomized trial of high-dose intravenous gammaglobulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenia purpura J Pediatr 123 1993 989 995
12. D Nugent D Hawkins T Pendergrass Long-term follow-up of refractory immune-mediated thrombocytopenia purpura (ITP) patients treated with high-dose dexamethasone therapy (Dex) Blood 86 suppl 1 1995 66a abstr
13. M Linares A Cervero P Colomina Chronic idiopathic thrombocytopenic purpura in the elderly Acta Haematol 93 1995 80 88